Nantahala Capital Management, LLC - 31 Mar 2025 SCHEDULE 13G Report for AVALO THERAPEUTICS, INC. Common Stock, $0.001 par value (AVTX)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
AVALO THERAPEUTICS, INC. Common Stock, $0.001 par value
Symbol
AVTX
Shares outstanding
10.7M shares
Disclosed Ownership
900K shares
Ownership
8.43%
Form type
SCHEDULE 13G
Filing time
15 May 2025, 16:36:03 UTC
Date of event
31 Mar 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 8.43% 900K 0 900K /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer
Wilmot B. Harkey 8.43% 900K 0 900K /s/ Wilmot B. Harkey Wilmot B. Harkey
Daniel Mack 8.43% 900K 0 900K /s/ Daniel Mack Daniel Mack